In view of the unique challenges caused by the coronavirus (COVID-19) pandemic, the Veterinary Medicines Directorate (VMD) has made a temporary change to the standard guidance on manufacturers of extemporaneous preparations for use under the cascade.
This is to allow the supply of extemporaneous product which is made direct to the end user by a third party who is a ManSA holder, in cases where the procedures set out in the attached statement from the VMD (PDF, 894KB, 3 pages) are observed.
This decision has immediate effect and will initially last until 30 April when we will review it.
The Veterinary Medicines Regulations 2013 continue to apply.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
